Burkholderia cepacia complex vaccines

Where do we go from here?

Gonzalo A. Pradenas, Brittany N. Ross, Alfredo Torres

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Burkholderia comprises a wide variety of environmental Gram-negative bacteria. Burkholderia cepacia complex (Bcc) includes several Burkholderia species that pose a health hazard as they are able to cause respiratory infections in patients with chronic granulomatous disease and cystic fibrosis. Due to the intrinsic resistance to a wide array of antibiotics and naturally occurring immune evasion strategies, treatment of Bcc infections often proves to be unsuccessful. To date, limited work related to vaccine development has been performed for Bcc pathogens. In this review, we have gathered key aspects of Bcc research that have been reported in recent years related to vaccine efforts, virulence, immune responses, and animal models, and use this information to inform the research community of areas of opportunity toward development of a viable Bcc vaccine.

Original languageEnglish (US)
Article number10
JournalVaccines
Volume4
Issue number2
DOIs
StatePublished - Apr 15 2016

Fingerprint

Burkholderia cepacia complex
Vaccines
Burkholderia
Immune Evasion
Chronic Granulomatous Disease
Gram-Negative Bacteria
Research
Cystic Fibrosis
Respiratory Tract Infections
Virulence
Animal Models
Anti-Bacterial Agents
Health
Infection

Keywords

  • Burkholderia cepacia complex
  • Cystic fibrosis
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Pharmacology
  • Drug Discovery
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Burkholderia cepacia complex vaccines : Where do we go from here? / Pradenas, Gonzalo A.; Ross, Brittany N.; Torres, Alfredo.

In: Vaccines, Vol. 4, No. 2, 10, 15.04.2016.

Research output: Contribution to journalReview article

Pradenas, Gonzalo A. ; Ross, Brittany N. ; Torres, Alfredo. / Burkholderia cepacia complex vaccines : Where do we go from here?. In: Vaccines. 2016 ; Vol. 4, No. 2.
@article{a818d5b230394319b967ef412a841c23,
title = "Burkholderia cepacia complex vaccines: Where do we go from here?",
abstract = "Burkholderia comprises a wide variety of environmental Gram-negative bacteria. Burkholderia cepacia complex (Bcc) includes several Burkholderia species that pose a health hazard as they are able to cause respiratory infections in patients with chronic granulomatous disease and cystic fibrosis. Due to the intrinsic resistance to a wide array of antibiotics and naturally occurring immune evasion strategies, treatment of Bcc infections often proves to be unsuccessful. To date, limited work related to vaccine development has been performed for Bcc pathogens. In this review, we have gathered key aspects of Bcc research that have been reported in recent years related to vaccine efforts, virulence, immune responses, and animal models, and use this information to inform the research community of areas of opportunity toward development of a viable Bcc vaccine.",
keywords = "Burkholderia cepacia complex, Cystic fibrosis, Vaccine",
author = "Pradenas, {Gonzalo A.} and Ross, {Brittany N.} and Alfredo Torres",
year = "2016",
month = "4",
day = "15",
doi = "10.3390/vaccines4020010",
language = "English (US)",
volume = "4",
journal = "Vaccines",
issn = "2076-393X",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Burkholderia cepacia complex vaccines

T2 - Where do we go from here?

AU - Pradenas, Gonzalo A.

AU - Ross, Brittany N.

AU - Torres, Alfredo

PY - 2016/4/15

Y1 - 2016/4/15

N2 - Burkholderia comprises a wide variety of environmental Gram-negative bacteria. Burkholderia cepacia complex (Bcc) includes several Burkholderia species that pose a health hazard as they are able to cause respiratory infections in patients with chronic granulomatous disease and cystic fibrosis. Due to the intrinsic resistance to a wide array of antibiotics and naturally occurring immune evasion strategies, treatment of Bcc infections often proves to be unsuccessful. To date, limited work related to vaccine development has been performed for Bcc pathogens. In this review, we have gathered key aspects of Bcc research that have been reported in recent years related to vaccine efforts, virulence, immune responses, and animal models, and use this information to inform the research community of areas of opportunity toward development of a viable Bcc vaccine.

AB - Burkholderia comprises a wide variety of environmental Gram-negative bacteria. Burkholderia cepacia complex (Bcc) includes several Burkholderia species that pose a health hazard as they are able to cause respiratory infections in patients with chronic granulomatous disease and cystic fibrosis. Due to the intrinsic resistance to a wide array of antibiotics and naturally occurring immune evasion strategies, treatment of Bcc infections often proves to be unsuccessful. To date, limited work related to vaccine development has been performed for Bcc pathogens. In this review, we have gathered key aspects of Bcc research that have been reported in recent years related to vaccine efforts, virulence, immune responses, and animal models, and use this information to inform the research community of areas of opportunity toward development of a viable Bcc vaccine.

KW - Burkholderia cepacia complex

KW - Cystic fibrosis

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=85016876955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016876955&partnerID=8YFLogxK

U2 - 10.3390/vaccines4020010

DO - 10.3390/vaccines4020010

M3 - Review article

VL - 4

JO - Vaccines

JF - Vaccines

SN - 2076-393X

IS - 2

M1 - 10

ER -